Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Endoscopic Studies I: Bronchoscopy and Thoracoscopy01:30

Endoscopic Studies I: Bronchoscopy and Thoracoscopy

349
Endoscopy is a non-surgical medical technique used to examine a person's internal organs and vessels. This lesson will focus on two types of endoscopic studies: bronchoscopy and thoracoscopy.
Bronchoscopy
Description
Bronchoscopy is a procedure that involves direct visualization of the larynx, trachea, and bronchi for diagnostic and therapeutic purposes. A flexible fiber optic or rigid bronchoscope is used to carry out the procedure. The fiber-optic bronchoscope is more frequently used due...
349

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Radiogenomic approach combining CT-based radiomics and liquid biopsy improves prognostic stratification in patients with advanced NSCLC.

The journal of liquid biopsy·2026
Same author

Disease characteristics and treatment outcomes in patients with resected early-stage ALK-positive non-small cell lung cancer from the randomized ALINA trial.

Lung cancer (Amsterdam, Netherlands)·2026
Same author

Epidermal growth factor receptor (EGFR) atypical mutations in non-small-cell lung cancer (NSCLC): 'Where the streets have no name'.

Critical reviews in oncology/hematology·2026
Same author

Actionable driver gene alterations in early-stage non-small cell lung cancer: a review.

Therapeutic advances in medical oncology·2026
Same author

Lorlatinib atypical safety profile in ALK-positive aNSCLC: tips for management from an Italian expert panel.

Future oncology (London, England)·2026
Same author

Crizotinib in Patients With <i>ROS1</i>-Positive NSCLC With or Without Brain Metastases: Post Hoc Analysis of Phase II METROS Trial.

JTO clinical and research reports·2025

Related Experiment Video

Updated: Nov 24, 2025

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.7K

Surgery for small cell lung cancer: When and how.

Monica Casiraghi1, Giulia Sedda1, Ester Del Signore2

  • 1Division of Thoracic Surgery, IEO, European Institute of Oncology, IRCCS, Milan, Italy.

Lung Cancer (Amsterdam, Netherlands)
|December 28, 2020
PubMed
Summary

Surgery may benefit select small cell lung cancer (SCLC) patients. Stage I SCLC patients who undergo surgical resection show significantly longer survival, suggesting they are ideal candidates for this approach.

Keywords:
Small-cell lung cancerSurgerySurvival

More Related Videos

Electromagnetic Navigation Transthoracic Nodule Localization for Minimally Invasive Thoracic Surgery
07:30

Electromagnetic Navigation Transthoracic Nodule Localization for Minimally Invasive Thoracic Surgery

Published on: May 4, 2022

3.6K
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.4K

Related Experiment Videos

Last Updated: Nov 24, 2025

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.7K
Electromagnetic Navigation Transthoracic Nodule Localization for Minimally Invasive Thoracic Surgery
07:30

Electromagnetic Navigation Transthoracic Nodule Localization for Minimally Invasive Thoracic Surgery

Published on: May 4, 2022

3.6K
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.4K

Area of Science:

  • Oncology
  • Thoracic Surgery
  • Cancer Research

Background:

  • The role of surgery in treating small cell lung cancer (SCLC) is under review due to emerging data from large observational studies.
  • Retrospective data suggest potential survival benefits for SCLC patients undergoing surgical intervention.

Purpose of the Study:

  • To evaluate the outcomes and survival results of patients diagnosed with SCLC who underwent surgery with curative intent.
  • To identify patient subgroups within SCLC that may benefit most from surgical treatment.

Main Methods:

  • Retrospective analysis of 324 SCLC patients treated between 1998 and 2018.
  • Comparison of overall survival (OS) using Kaplan-Meier and Cox regression analyses for patients who underwent surgical resection.
  • Evaluation of patient stages and adjuvant treatment modalities, including chemotherapy (CT) and radiotherapy (RT).

Main Results:

  • Of 65 patients undergoing surgical resection, 39 had upfront surgery, and 24 had surgery after chemotherapy (CT) or CT plus radiotherapy (RT).
  • Patients with clinical stage I SCLC who underwent surgical resection demonstrated significantly longer survival, with a 5-year OS of 62.9% (p < 0.0001).
  • Overall median survival at 1, 5, and 10 years was 81.4%, 41.4%, and 25.4%, respectively.

Conclusions:

  • Stage I SCLC patients are the best candidates for surgical resection within a multidisciplinary treatment setting.
  • For patients with stage II and III SCLC, careful selection for surgery is crucial due to poorer survival outcomes; alternative therapies should be considered.